Home › Scleroderma › New Jersey › Edison
Scleroderma clinical trials in Edison, NJ
4 studies for Scleroderma are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- Rutgers Robert Wood Johnson Medical School, New Brunswick · 3 mi away
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi away
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Astera Cancer Care, East Brunswick · 6 mi away
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Robert Wood Johnson Medical School, New Brunswick · 3 mi away
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Chicago, IL10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Durham, NC7 studies
- Los Angeles, CA7 studies
- New Orleans, LA6 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
Other studies in Edison
- Breast Cancer68 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer29 studies
- Colorectal Cancer23 studies
- Lung Cancer23 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.